BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 23395853)

  • 1. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
    J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.
    Guleria RS; Choudhary R; Tanaka T; Baker KM; Pan J
    J Cell Physiol; 2011 May; 226(5):1292-307. PubMed ID: 20945395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid X receptor agonists attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes through LKB1-dependent anti-fibrosis effects.
    Chai D; Lin X; Zheng Q; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J
    Clin Sci (Lond); 2020 Mar; 134(6):609-628. PubMed ID: 32175563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from diabetic cardiomyopathy - putative role of the retinoid receptor-mediated signaling.
    Rassaf T; Kelm M
    J Mol Cell Cardiol; 2013 Jun; 59():179-80. PubMed ID: 23542309
    [No Abstract]   [Full Text] [Related]  

  • 5. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
    Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
    Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.
    Singh AB; Guleria RS; Nizamutdinova IT; Baker KM; Pan J
    J Cell Physiol; 2012 Jun; 227(6):2632-44. PubMed ID: 21882190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathway.
    Nizamutdinova IT; Guleria RS; Singh AB; Kendall JA; Baker KM; Pan J
    J Cell Physiol; 2013 Feb; 228(2):380-92. PubMed ID: 22718360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
    Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
    Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
    Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
    Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.
    Bhatt NM; Aon MA; Tocchetti CG; Shen X; Dey S; Ramirez-Correa G; O'Rourke B; Gao WD; Cortassa S
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H291-302. PubMed ID: 25485897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
    He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
    Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.
    Pan J; Guleria RS; Zhu S; Baker KM
    J Clin Med; 2014 Jun; 3(2):566-94. PubMed ID: 26237391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
    Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
    J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.